How can Mativ Holdings, Inc. accelerate customer growth by expanding its high-performance materials in life sciences?
Mativ Holdings, Inc. can capture higher-margin shares by focusing on life sciences, water filtration, and sustainable packaging where technical specs and regulation raise barriers. Recent 2025 demand for bioprocess filtration and stricter packaging regs support this pivot. Mativ Business Model Canvas

Mativ should target OEM partnerships and custom formulations to deepen customer ties; demand signals in 2025 bioprocessing and water treatment markets make this a timely move.
WWhere Could Mativ's Next Customer or Product Expansion Come From?
The next customer and product expansion for Mativ Holdings, Inc. will come from environmental regulation-driven demand and industrial electrification-chiefly semiconductor-grade filtration and EV battery materials-where rising air-quality standards and thermal-management needs create clear, near-term pull.
Global push for semiconductor self-sufficiency is driving an estimated 7 percent CAGR in high-purity filtration media; that aligns with Mativ company growth in Advanced Technical Materials. Simultaneously, demand for specialized release liners and thermal-management substrates in EVs creates adjacent-product opportunities that fit Mativ product strategy.
Asia-Pacific manufacturers upgrading air-quality standards drive higher unit volumes for premium HVAC and HEPA filters; this market expansion Mativ can pursue via regional partnerships and targeted customer acquisition, increasing international revenue share.
Mativ product strategy can expand revenue by bundling high-margin filtration media with release liners and battery component materials for OEMs and battery pack makers-boosting average order value and CLV (customer lifetime value) through cross-selling and upselling tactics.
The most realistic growth driver in 2025-2026 is regulatory tightening plus industrial electrification: stricter clean-air rules and EV production scale will likely lift demand for Mativ's technical media and thermal-management materials, supporting sustained margin expansion and Mativ customer acquisition.
See a detailed Product Model of Mativ Company for alignment with product development for Mativ and market expansion Mativ strategies: Product Model of Mativ Company
Mativ SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
WWhat Is Mativ Building to Unlock More Demand?
Mativ Holdings, Inc. is scaling melt-blown capacity, launching PFAS-free fiber solutions, consolidating legacy brands, and packaging polymer-plus-fiber hybrid offerings to convert demand into sales and win global accounts.
Mativ is pushing into healthcare filtration and sustainable consumer packaging across North America, Europe, and Asia, targeting large CPG and industrial accounts that require consistent global supply. The move supports market expansion Mativ and aims to increase international revenue share above 40% of total sales by end-2025.
Mativ launched PFAS-free fiber-based solutions in 2025 within Fiber-Based Solutions to meet brand migration away from plastics. They also offer hybrid polymer-fiber materials for filtration and protective films, differentiating the Mativ product strategy from narrower competitors.
The company is aggressively scaling melt-blown capacity-critical for high-efficiency filtration-adding capacity targets announced in 2025 to support mask, HVAC, and industrial filtration demand. Integrated polymer and fiber lines reduce lead times and improve gross margins via operational synergies.
Post-merger integration enables bundled technical solutions and faster cross-selling into existing accounts; Mativ is aligning sales teams and labs to accelerate joint product launches and capture strategic partnerships with global consumer brands.
2025 capex prioritizes melt-blown lines and fiber R&D, while GTM work consolidates legacy brands to simplify procurement for multinational accounts. Execution targets include standardized contracts and a single global pricing framework to improve win rates and shorten sales cycles.
The key bet is marrying polymers and PFAS-free fibers into certified filtration and food-contact films-products that unlock premium pricing and multi-year OEM agreements. Success would drive higher average selling prices and improve customer retention strategies Mativ across core segments.
See a detailed company write-up: Customer Profile of Mativ Company
Mativ VRIO Analysis
- Complete VRIO Analysis
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
WWhat Could Weaken Mativ's Product-Market Fit or Demand?
The biggest threat to Mativ Holdings, Inc.'s product-market fit is rapid input-cost swings and material substitution that can erase margin advantages and reverse demand for fiber-based or bio-based alternatives.
Slower growth in consumer packaged goods and foodservice volumes or delayed retail reopening reduce demand for sustainable packaging. If buyers prioritize near-term cost over sustainability, Mativ company growth tied to premium fiber and specialty solutions could slow, affecting Mativ product strategy and customer acquisition.
Falling resin prices or cheaper mechanically recycled plastics can prompt substitution reversal, squeezing average selling prices. Intense rivalry from larger converters with lower cost of capital could force aggressive pricing, lowering margins and challenging Mativ product strategy and pricing tests like A/B experiments.
Mativ's current leverage - management targets reducing net debt/EBITDA toward 2.5x-3.0x by 2026 - could limit R&D and capex versus larger peers. If global industrial slowdowns cut organic cash flow, the company may under-invest in product development for Mativ and delay rollout of the Mativ product innovation roadmap for growth.
The clearest single risk is material-cost volatility coupled with substitution risk: if polymer resin and specialty pulp prices fall or chemical recycling scales faster than projected, demand for higher-margin fiber alternatives may reverse, compressing EBITDA and slowing Mativ company growth in 2025 and into 2026. See customer-choice context in Why Customers Choose Mativ Company.
Mativ Marketing Mix
- Complete Marketing Mix Analysis
- Effortlessly Communicate Your Business Strategy
- Investor-Ready Format
- 100% Editable and Customizable
- Clear and Structured Layout
HHow Strong Does Mativ's Customer-Led Growth Story Look?
The customer-led growth story for Mativ Holdings, Inc. looks strong but execution-dependent: repositioning into non-discretionary end markets and completed divestitures provide a credible base, yet hitting sustained organic targets requires consistent cross-sell and product innovation execution.
Mativ company growth is now rooted in healthcare and environmental filtration, reducing cyclicality and raising baseline demand. Management's 3-5 percent organic growth target for 2025 and 2026 is plausible given recent portfolio simplification and early synergy realization from SWM and Neenah integrations.
- Strongest growth support: exposure to essential, non-discretionary markets-healthcare filtration and environmental filtration-accounting for a rising share of revenue after 2025 divestitures.
- Key strategic build-out: cross-selling and Mativ product strategy integration between legacy SWM and Neenah lines to expand addressable market and accelerate product development for Mativ.
- Main downside risk: execution shortfall-failure to convert theoretical synergies into measurable customer acquisition or CLV gains would stall the Mativ customer acquisition ramp and constrain margin recovery.
- Overall 2025/2026 judgment: mixed-to-strong-leaner cost base and focused go-to-market give upside to Mativ product innovation roadmap for growth, but near-term delivery risk keeps outcomes dispersed around the 3-5% organic growth target.
Mativ's recent divestiture program completed in 2025 freed capital and reduced low-margin exposure; management expects to redeploy about $100-150 million in working capital and targeted R&D from 2025 into 2026 to support product development for Mativ and market expansion Mativ initiatives.
Cross-selling traction: early 2026 sales data show a ~1.2 percentage-point uplift in blended account penetration where legacy SWM filtration products were offered alongside Neenah specialty substrates-an initial sign the Mativ cross-selling and upselling tactics to increase revenue are working, though absolute revenue contribution remains single-digit percent of total sales.
Customer segmentation and targeting strategy: Mativ is prioritizing healthcare OEMs, municipal water/air treatment operators, and industrial automation integrators; these three segments now represent an estimated 55-60% of addressable revenue versus ~45% pre-pivot, improving revenue predictability.
Product roadmap and pricing: prioritized roadmap emphasizes higher-margin specialty filtration and automation-compatible products with launch cadence targeting 6-8 new SKUs in 2026. Management pilots dynamic pricing and A/B testing in select markets to lift average selling price (ASP) by a targeted 3-5% without hurting volume.
Customer retention and CLV: initiatives-expanded field technical support, bundled service contracts, and digital order portals-aim to increase retention by ~150-250 bps within 12-18 months, which would raise customer lifetime value and support Mativ e-commerce strategies to boost product sales.
Channel and go-to-market: sales funnel optimization techniques include dedicated account teams for strategic healthcare customers, factory-direct programs for municipal buyers, and distributor enablement for international expansion into EMEA/APAC; expected effect is faster conversion and reduced sales cycle by 10-15%.
Financially, mid-2026 positioning: gross margin recovery dependent on realizing synergies; management guidance projects adjusted EBIT margin expansion of ~150-250 bps by end-2026 assuming synergy capture and pricing initiatives succeed.
Key metrics to watch quarterly: organic revenue growth rate vs. 3-5% target, cross-sell penetration percentage, ASP movement from pricing tests, retention delta in bps, and R&D spend redeployment versus the committed $100-150 million range.
For a company narrative and brand context, see Brand Story of Mativ Company.
Mativ Ansoff Matrix
- Complete ANSOFF Matrix
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
Related Blogs
- What Do the Mission, Vision, and Values of Mativ Company Say About Its Brand?
- How Did Mativ Company Become the Brand It Is Today?
- Who Runs Mativ Company and Shapes Its Direction?
- How Does Mativ Company's Product and Business Model Work?
- How Does Mativ Company Attract, Convert, and Keep Customers?
- Who Are the Core Customers of Mativ Company?
- Why Do Customers Choose Mativ Company Over Competitors?
Frequently Asked Questions
Mativ's next growth is tied to environmental regulation-driven demand and industrial electrification. The blog points to semiconductor-grade filtration, EV battery materials, and air-quality upgrades as the clearest near-term opportunities for product and customer expansion.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.